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A CELLULAR AUTOMATA MODEL OF
TUMOR-IMMUNE SYSTEM INTERACTIONS
D.G. MALLET AND L.G. DE PILLIS
Abstract. We present a hybrid cellular automata-partial differ-
ential equation model of moderate complexity to describe the inter-
actions between a growing tumor next to a nutrient source and the
immune system of the host organism. The model allows both tem-
poral and two-dimensional spatial evolution of the system under
investigation and is comprised of biological cell metabolism rules
derived from both the experimental and mathematical modeling
literature. We present numerical simulations that display behav-
iors which are qualitatively similar to those exhibited in tumor-
immune system interaction experiments. These include spherical
tumor growth, stable and unstable oscillatory tumor growth, satel-
litosis and tumor infiltration by immune cells. Finally, the rela-
tionship between these different growth regimes and key system
parameters is discussed.
1. Introduction
The response of the immune system to mutated and potentially can-
cerous cells is the body’s natural defense against tumor growth. Both
the functioning of the immune system and the growth of tumors involve
highly complex processes, and coupled, the tumor-immune interactions
form an elaborate system that is not yet fully understood by either ex-
perimentalists or theoreticians.
Tumor growth and the dynamics of the immune system have been a
significant focus for mathematical modeling over the past three decades.
Evolving from the early chemical diffusion and differential equation
models of Burton [11] and Greenspan [34], descriptions of tumor growth
have been presented more recently using partial differential equations
(PDEs) (see for example [13, 15, 58, 42, 53]) and cellular automata
(CA) (see for example [2, 21, 6, 26, 35, 49]). An excellent review of
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mathematical models of tumor growth was recently given by Araujo
and McElwain [4].
Similarly, a variety of mathematical models exist describing the im-
mune system in its various roles. Perelson provides a substantial review
of the immune system before demonstrating the process of modeling
the immune system from the point of view of a physicist [52]. Seiden
and Celada developed a computer program based on a bit-string cel-
lular automata called the IMMSIM model [67]. The IMMSIM model
in its current form includes both the humoral and cellular immune re-
sponses. A number of researchers have also modeled the kinetics of the
cellular immune response, including Merrill [46], Callewaert et al. [17],
and Perelson and Macken [51].
A number of mathematical models also have coupled tumor growth
with immune system dynamics. Usually, these models are fully deter-
ministic, comprised of a series of ordinary or partial differential equa-
tions (ODEs or PDEs) describing the dynamics of, for example, tumor
cells, host cells, and immune cells [5, 7, 8, 32, 37, 40, 41, 44, 58, 59, 57,
55, 71]. An excellent review of tumor-immune system models, both at
the cellular and sub-cellular levels, is given by Adam and Bellomo [1].
Immunotherapy has also been investigated using similar deterministic
models coupled with optimal control theory [10, 54, 56].
Most of these tumor-immune system models are fully deterministic,
and although there are several excellent models that include spatial
interactions between tumor and immune cells using chemotaxis terms
in the governing PDEs, simulation results often focus mainly on one-
dimensional or radially symmetric spatial growth and the temporal
evolution of the cell species under investigation [44, 58, 57]. In this
paper, we also model temporal evolutions but furthermore include two-
dimensional spatial evolution by employing a hybrid cellular automata–
partial differential equation modeling approach.
This deterministic-stochastic approach has the benefits of being con-
ceptually accessible and computationally straightforward to implement.
Unlike the spatio-temporal models noted above, this model allows for
the consideration of individual cell behavior and associated random-
ness, rather than applying a general rule to a collection of cells (for
example, with regard to cell migration). Because of the structure of
the model, which simulates chemical diffusion through deterministic
PDEs and cell behavior through a set probabilistic rules, the model
and its computational implementation are very flexible. It can easily
be extended or modified as new data become available or when differ-
ent situations arise requiring the inclusion of new chemical species or
cell behavior rules.
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Few if any other models, consider the spatio-temporal and partially
stochastic interactions between individual tumor cells and multiple
populations of individually recognised immune cells, such as is the case
in this work. Furthermore, biologists and immunologists also have a
limited understanding of such interactions. As such we believe it is
important to focus on early tumor growth before tackling the more
complicated vascularised stages of growth in such an investigation.
It should also be noted that the strategy employed in this work to
describe the tumor dynamics and interactions with the immune system
is quite different from the continuous-discrete hybrid used by Ander-
son and Chaplain in their models of angiogenesis [3]. Anderson and
Chaplain employ discrete models closely related to continuous PDE-
based angiogenesis models whereas in this work we consider a mixture
of continuous PDEs for chemical quantities and a discrete cell-based
description for biological cell species with phenomenologically sourced
probabilities for cell dynamics. It is also different from the off-lattice
approach, another technique that can be used in this type of research,
which is employed by Drasdo and coworkers [22, 23] and allows for the
modeling of forces on the cells (such as deformation forces).
The hybrid CA-PDE modeling approach has been successfully used
in the past to model tumor growth, chemotherapeutic treatment and
the effects of vascularization on tumor growth [49, 26, 2, 27]. Here we
use reaction-diffusion PDEs to describe chemical species such as growth
nutrients, and a cellular automata strategy to track the tumor as well
as two distinct immune cell species. Together, these elements simulate
the growth of the tumor and the interactions of the immune cells with
the tumor-growth.
Using the hybrid CA-PDE model, we aim to demonstrate the com-
bined effects of the innate and specific immune systems on the growth
of a two-dimensional tumor. This is accomplished through the devel-
opment of a model with cellular behaviors related to those described
in the experimental literature and by considering the ODE models of
tumor-immune system interactions developed in other works (such as
[40, 54, 56]).
This model is useful because it allows for predictions to be made
with regard to the behavior of the initial stages of solid tumor growth
and the growth of undetectable metastases. In this model, we study
a cluster of tumor cells to which nutrient is made available through a
nearby blood vessel. Note that in a model of later stage development,
one might wish to incorporate nutrient delivery through blood vessel
sources interspersed throughout the tumor cell cluster as has been at-
tempted by Alarcon et al. [2], McDougal et al. [45] and Gatenby [33].
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However, in this work we focus on the early stage model as the study
of early stage tumor models continues to be of interest (see, for exam-
ple, [59, 60, 68, 12, 14, 61, 72, 73, 28, 29, 30, 57, 62, 76]). One of the
reasons for modeling tumor growth in its early stages is to allow for
the development and validation of a foundational model prior to the
inclusion of potentially confounding model features such as full vascu-
larization and metastatic behavior. Another reason is to allow for the
modeling of the situation in which a patient whose primary tumor has
been resected, but who may additionally require post-operative ther-
apy to ensure that undetectable metastases are being treated. These
undetectable metastases are reasonably modeled as early stage tumors.
We will demonstrate different types of tumor growth including spher-
ical and papillary (branchy) growth, stable and unstable oscillatory
growth, and lymphocyte-infiltrated growth, and show the dependence
of these different morphologies on key model parameters related to the
tumor-immune system interactions. The model developed here is also
useful as it provides an extension to previous models lacking an im-
mune system component, that may be built upon in the future with
the addition of other cell and chemical species in order to test and
validate new hypotheses.
In a study of cell transfer therapy for metastatic melanoma patients,
Rosenberg et al. comment on the difficulty of deriving meaningful
results from human experiments due to the variations in cell types,
tumor types, immune states, and more fundamentally the human sub-
jects themselves [64]. While Rosenberg et al. suggest a solution to such
a problem is to treat the same patient in differing ways over a period
of time, another more flexible and less hazardous method is through
mathematical modeling – the pathway taken in this paper to examine
the effects of the immune system on tumors.
In Section 2 we present a short overview of the biology underlying
the mathematical model that will be developed in Section 3. In Sec-
tion 4, a number of representative simulation outputs are presented
along with a discussion of the model results in general. Finally, in Sec-
tion 5, the results of the model simulations are discussed and related
to the biological problem, and a number of ideas for future research are
proposed.
2. Biological Background
Consider first the biology underlying the growth of a tumor. In
normal tissue, division and death of cells are tightly balanced. This
balance allows the body to construct and maintain the tissue so that
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it may carry out its particular purpose in the survival of the organ-
ism. The growth of a tumor starts with a single mutated cell that
is able to proliferate inappropriately by either avoiding apoptosis or
undergoing excessive proliferation. This leads to an imbalance in the
cell death:division ratio when compared with that observed in normal
tissue [47, 74].
In this paper we consider a tumor in the early stage of growth. Avas-
cular growth, that which occurs when the tumor does not have its own
vasculature, is the early phase of tumor growth that follows cell mu-
tation [16]. During this stage, nutrients required for growth (such as
glucose, oxygen [31, 70] or some other relevant nutrient) are supplied
to the tumor via diffusion from distant blood vessels [16]. Aggressive
growth, including the possibility of metastasis, occurs after an avas-
cular tumor has developed its own vascular network and will not be
considered in the model developed in this paper. Rather, we focus on
the early stages of tumor growth in which the tumor is simply adja-
cent to nutrient supplying vasculature to allow for an investigation of
the initial interactions between the immune system and the emerging
tumor.
As a result of the external nutrient supply, avascular tumors often
develop into approximately radially symmetric structures. Ferreira et
al. have also shown that branch-like structures develop when tumor
cells divide rapidly and consume nutrients required for mitosis much
more rapidly than those required for survival [26]. In radially symmet-
ric tumors, the growing tumor is characterized by up to three layers -
an outer rim of dividing cells with easy access to nutrients, an inner
shell of non-dividing cells subjected to lower nutrient levels, and a cen-
tral core of necrotic (dead) cells that die due to extremely low nutrient
concentrations.
Tumor growth is often suppressed either naturally by the immune
system of the host, or by outside intervention using chemotherapeutic
and other drug treatments. The purpose of this study is to investi-
gate the effects of the immune system on tumor growth. The effects
of chemotherapeutic drugs have been investigated in similar work by
Ferreira et al. [27] and in the ODE models of de Pillis and Radunskaya
[54].
Fundamental to the immune system are the concepts of “self” and
“non-self”. The components of the immune system are located through-
out the body and are charged with the responsibility of detecting and
destroying entities which are foreign to the body (non-self), such as
tumor cells, while simultaneously allowing entities that belong in the
body (self) to remain and carry out their function [50, 52]. Tumor
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cells present different antigens from those of the cells from which they
have mutated. These are the antigens that alert the immune system
to the non-self nature of the tumor cell. When there is a failure in
the immune system’s surveillance of tumor cells, or when the immune
suppression of tumor cells is insufficient, a tumor is able to grow and
invade surrounding tissue [47].
While other components (such as macrophages) exist, in the model
developed in this research we consider only two cell types to comprise
the immune system. In particular, we model the natural killer (NK)
cells of the innate immune system and the cytotoxic T lymphocytes
(CTLs) of the specific immune system. Essentially it is in this way
that the model developed herein is different from that of Ferreira et al.
Both are hybrid PDE-CA models, but this work introduces the impact
of the immune response on tumor development.
Natural killer cells are able to find and eliminate malignant cells
while they undertake surveillance of the body for foreign components
[47]. Forming part of the innate immune system, natural killer cells are
cytotoxic cells that are highly effective in lysing multiple (but specific)
tumor cell lines [50]. Unlike cells of the specific immune system, which
are drawn to a location due to the presence of antigen, the natural
killer cells are constantly present guarding the body from infection and
disease.
On the other hand, cytotoxic T lymphocytes are able either to lyse or
to induce apoptosis in cells presenting specific antigens, such as tumor
cells [50]. Unlike NK cells, CTLs are only able to recognize a specific
antigen or tumor cell line. It is known however, that these cells are
able to destroy more than one tumor cell during their life cycle while a
single natural killer cell generally kills very few [39]. After destroying
the target cell, the CTLs move on in search of other antigen presenting
cells.
Using the modeling framework described in this paper, we also demon-
strate lymphocyte infiltration of tumors. This is of particular inter-
est given recent experimental research that suggests improved survival
rates for patients with intratumoral immune cells [77]. Infiltration of
T cells into the tumor mass can also lead to fibrosis and necrosis, and
therefore tumor destruction and antitumor immunity [66, 69]. Tumors
reduced in size are then more amenable to treatment by traditional ra-
diation methods. Numerical solutions produced using the model devel-
oped in this paper are in qualitative agreement with the experimental
results demonstrated by Zhang et al. [77], Schmollinger et al. [66], and
Soiffer et al. [69].
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Variable Description
N(x, y, t) mitosis nutrient concentration
M(x, y, t) survival nutrient concentration
H host cell number
T tumor cell number
I total immune cell number
Parameter Description
α rate of consumption of nutrient by host and immune cells
λN excess consumption factor of tumor over non-tumor cells of N nutrient
λM excess consumption factor of tumor over non-tumor cells of M nutrient
Pnec probability of tumor cell death due to necrosis
θnec shape parameter for necrotic death probability curve
Pimdth probability of tumor cell death due to the immune system
Pdiv probability of tumor cell division
θdiv shape parameter for cell division probability curve
Pmig probability of tumor cell migration
θmig shape parameter for migration probability curve
κ number of possible tumor cell kills for a single CD8+ cell
I0 background level of natural killer cells
Pnk probability of the production of a new natural killer cell
PL probability of induction of a CTL due to CTL/TC interaction
θL shape parameter for CTL induction probability curve
PLD probability of CTL death
θLD shape parameter for CTL death probability curve
Table 1. Variables and model parameters used in the
hybrid model.
In the following section, the above biological description will be
translated into the mathematical model used to simulate tumor growth
and the interaction of the tumor with the immune system.
3. Model Formulation
In this model we consider the nutrient limited growth of an early
stage tumor and the dynamic interplay between the immune system
and the growing tumor. The model involves a combination of reaction-
diffusion equations for the nutrient species and numerous rules of evo-
lution for the cellular automaton description of the various cell-types
that comprise the tissue-tumor environment.
We consider a tumor growing on a square domain Ω = [0, L]× [0, L],
where L is the length of each side of the domain. The spatial domain
represents a two-dimensional patch of tissue that is supplied with nu-
trients by blood vessels that occupy the y = 0 and y = L boundaries,
as shown in Figure 1. The remainder of the space is partitioned into a
regular grid in which the various cell types reside, and through which
the nutrient species diffuse. The grid is partitioned in such a way that
each cellular automata grid element corresponds in size with the actual
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Figure 1. Schematic of the cellular automata physical
domain. The conditions imposed on the four boundaries
are indicated. The solid bars (top and bottom) represent
the capillaries while different cell types are shown filling
the spaces in the grid.
biological cells of interest (10−20µm – [2, 41]). While finer grids can be
used for the nutrient PDE solver, sufficient accuracy was gained with
the matching grids and this allowed for faster computation of solutions.
We simulate the temporal progression of the system using two main
steps. First, the partial differential equations for the nutrient species
are solved, then with dependence upon the new nutrient fields the
cellular activities (such as motion and division) are carried out. Each
temporal iteration therefore corresponds to the period of tumor cell
division. That is, a period of approximately 0.5− 10 days, depending
on the cell type in question [37, 63]. The cellular automaton rules,
along with a description of the reaction-diffusion equations are given
below. For reference, the variables and parameters used in the model
are listed along with descriptions in Table 1.
3.1. Reaction-diffusion Equations. Reaction-diffusion equations have
been widely used since the early models of Greenspan [34] and Bur-
ton [11] for the mathematical treatment of nutrient species, and many
other chemical species, in tumor-growth models. In a similar man-
ner, reaction-diffusion partial differential equations are also employed
in this work to describe the distribution of two chemicals necessary for
mitosis and cell survival.
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As in the work of Ferreira et al. [26], [27], here we consider two
nutrient species – the first nutrient being a necessary component of the
cell division processes, while the second is essential for cellular survival.
The nutrients diffuse throughout the tissue space, and as they do so
they are consumed by the different cells that are resident in tissue.
The nutrient species are governed by the following equations:
(1)
∂N
∂t
= DN∇2N − k1HN − k2TN − k3IN,
(2)
∂M
∂t
= DM∇2M − k4HM − k5TM − k6IM,
where N and M represent the proliferation nutrient and survival nu-
trient, respectively. The cell species are identified by H for host cells
(normal tissue), T for tumor cells, and I for immune cells. Also, DN
and DM are the diffusion coefficients for the two nutrients, k1, k2 and
k3 are the rates of consumption of proliferation nutrient by host cells,
tumor cells and immune cells, respectively, while k4, k5 and k6 are the
corresponding rates for the survival nutrient.
So as to maintain continuity of comparison with the work of Fer-
reira et al., upon which the above equations are based, we assume
that the diffusion coefficients for both nutrients are equal. That is,
DM = DN = D. Furthermore, we make similar assumptions for
the consumption rates of the two chemicals by non-tumorous cells, and
consider both normal tissue and immune cells to consume nutrients at
the same rate such that k1 = k4 = k3 = k6. To model the increased
nutrient consumption of tumor cells compared with that of normal
cells, we further assume that the consumption rate of the tumor cells
is a constant multiple of the host cell consumption rates. That is,
k2 = λNk1 and k5 = λMk1, where λN ≥ 1 and λM ≥ 1 determine the
excess consumption by the tumor cells of the two types of nutrient.
As mentioned above, we assume blood vessels pass through the area
of interest and take for example, a pair of blood vessels residing along
the boundaries y = 0 and y = L. Given that the blood vessel is the pri-
mary source of nutrient supply, the conditions at those boundaries for
both reaction-diffusion equations take on the formN(x, 0) = N(x, L) = N0
and M(x, 0) = M(x, L) = M0. On the sides (x = 0 and x = L) we
assume periodic boundary conditions.
To nondimensionalise the reaction-diffusion equations, we assume
the same variable transformations used by Ferreira et al. [26], such
that
(3) tˆ =
Dnt
L2
, (xˆ, yˆ) =
(nx
L
,
ny
L
)
, Nˆ =
N
N0
, Mˆ =
M
M0
,
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where variables under hats are dimensionless. With these transforma-
tions, equations (1) and (2) in their nondimensionalised form become
(4)
∂N
∂t
= ∇2N − α2(H + I)N − λNα2TN,
(5)
∂M
∂t
= ∇2M − α2(H + I)M − λMα2TM,
where α2 =
k1L
2
Dn2
is the dimensionless rate of consumption of nutrient
by host and immune cells and hats have been dropped for notational
simplicity.
The change to nondimensional variables also alters the source condi-
tions on the y = 0 and y = L boundaries. These becomeN(x, 0) = N(x, n) = 1
and M(x, 0) = M(x, n) = 1.
3.2. Cellular Automata Rules. While the chemical species are gov-
erned by deterministic reaction-diffusion equations, the evolution of the
four cell species considered in this model proceeds according to a com-
bination of probabilistic and direct rules. These are outlined below.
As in Ferreira et al., we consider a simplification of the host cells being
passive where, other than their consumption of nutrients, they allow
tumor cells to freely divide and migrate.
3.2.1. Tumor Cells. The tumor cells in this model undergo the processes
of division, death, and movement. These processes depend upon nu-
trient levels, the presence of cells of the immune system, and crowding
due to the presence of other tumor cells. At each time step, each cell
is randomly assigned the option to divide, move or die, after which
various conditions are checked to determine whether or not the action
will be carried out. While it is possible that the timescales of such
processes may vary (between or within cell types), for generality we
consider the timescales to coincide with the time step of the numeri-
cal solution method. To effect the various changes to the tumor cell
population, we impose the following cellular automata rules.
Due to their inherent mutations by which they avoid apoptosis, we
do not consider natural death of tumor cells. We do however, consider
two pathways to tumor cell death:
Death due to insufficient nutrient. If a cell is marked for death,
the probability of cell death,
(6) Pnec = exp
[
−
(
M
Tθnec
)2]
,
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is calculated to determine whether or not the action will be carried out.
This probability term implies that the possibility of nutrient related
death decreases as the ratio of nutrient M to the number of tumor
cells T increases, with shape parameter θnec. This probability is of the
same form as that used by Ferreira et al. [26].
Death due to the immune system. When the cells of the immune
system arrive in a close neighborhood of a tumor cell, the immune cells
try to kill the tumor cell, with an intensity directly related to the
strength of the local immune system. The probability of death in this
case is given by
(7) Pimdth = 1− exp
−(∑
j∈η
Ij
)2 ,
where the summation counts the total number of immune cells (both
NK and cytotoxic T lymphocyte), I, in the neighborhood, η, of the
relevant tumor cell. Without further experimental information, we
consider η to include the eight CA elements surrounding element j.
Tumor cells can undergo mitosis provided the local level of the mi-
tosis nutrient, N , is sufficient.
Tumor cell division. If a cell is marked for division, the probability
of cell division,
(8) Pdiv = 1− exp
[
−
(
N
Tθdiv
)2]
,
is calculated to determine whether mitosis occurs. This term implies
that the chance of division increases with the ratio of nutrient concen-
tration to the number of tumor cells, with a shape parameter θdiv, and
is of the form used by Ferreira et al. [26].
The grid location upon which the daughter cell is placed depends
upon the cells occupying the neighborhood of the mother cell. For
example, a dividing cell with at least one host cell or necrotic space
surrounding it will place its daughter cell randomly in one of those non-
cancerous locations and either destroy the host cell or simply replace
the necrotic material. On the other hand, if all elements around the
dividing cell are filled with tumor cells, the daughter cell will be placed
in the neighboring element containing the fewest tumor cells. This may
be viewed as one approach to modeling tumor cell crowding.
Finally, tumor cells may also be chosen to move to a neighboring
location on the cellular automata grid.
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Tumor cell migration. Cells marked for migration do so with a
probability given by
(9) Pmig = 1− exp
[
−T
(
M
θmig
)2]
,
such that the probability that the cell migrates increases with the tu-
mor cell count of the current element. This is another way that cell
crowding effects are accounted for in the model. This probability term,
proposed by Ferreira et al. [26], suggests that the likelihood of tumor
cell movement increases with higher levels of the nutrient, M , possibly
because nutrients allow the cell to proceed with migratory processes. It
has also been considered that a cell may prefer to move away from areas
of low nutrient concentration, and in this case the M in the probabil-
ity term would appear in the denominator. Preliminary experiments
with this model alteration have produced little qualitative difference to
solutions, however this will be investigated further in future research.
The grid location to which the migrating cell relocates again depends
upon the cells that occupy its neighborhood. Migrating cells that have
necrotic space or host cells in their immediate neighborhood will ran-
domly move to one of these elements, replacing the original occupant
as was the case for a daughter cell above. When all neighboring au-
tomaton elements are occupied by tumor cells, the migrating cell will
move to the element with the fewest cancer cells - again in an attempt
to move away from crowded areas of the tumor. While it has not been
considered in this work, directed motion such as chemotaxis could be
introduced to the model here by requiring the moving cell to move
toward areas of higher nutrient levels.
While equations (6), (8) and (9) are taken from Ferreira et al. [26],
and equation (7) is constructed from a similar point of view, differ-
ent functional forms may indeed lead to slightly different results from
the quantitative viewpoint, and with more experimental justification
it will be possible to give more accurate probability functions. This is
currently a topic of further research.
3.2.2. Immune Cells. Two separate immune cell populations are con-
sidered here - the natural killer cells of the innate immune system, and
cells of the specific immune response, represented by the cytotoxic T
lymphocytes.
Here we consider CTLs to be recruited to the tumor location from
external sources when natural killer cells lyse tumor cells or when CTLs
and tumor cells interact. Furthermore, the cells of the specific immune
system are able to lyse tumor cells more than once [39]. Hence, we
CA-PDE MODEL OF TUMOR-IMMUNE INTERACTIONS 13
assume that CTLs may kill a fixed number of tumor cells and use κ to
represent this kill parameter.
Like the tumor cells, at each time step, immune cells that are near
tumor cells are marked with the intent to carry out tumor cell lysis.
On the other hand, those immune cells with no nearby tumor cells are
randomly assigned to either die off or to attempt to migrate in search
of tumor cells.
In this model we assume that natural killer cell numbers are roughly
stable around some “normal” constant proportion, I0, of the total num-
ber of cells in the domain. This is achieved by imposing an initial
condition where I0n
2 NK cells are randomly placed over the domain of
interest.
Natural killer cell production. In order to maintain the normal
level of the natural killer cell population, we impose a form of birth on
the evolution of the immune cell population. At each time step and for
each CA grid element, a random number is generated and compared
with the probability of natural killer cell production:
(10) Pnk = I0 − 1
n2
∑
allCA
I.
If the random number is less than Pnk and the element is not currently
occupied by a tumor cell, then a new natural killer cell will be placed in
that element. This probability term, Pnk, effectively compares the cur-
rent NK cell population in the domain of interest with the proportion
that is expected in the normal situation. The effect of this strategy is
that it allows NK cells to arrive in open spaces, possibly from below
the domain of computation (in an attempt to incorporate at least some
three-dimensionality in the model), but also in free spaces near the two
blood vessels (at the top and bottom of domain).
Immune cell lysis of tumor cells. If an immune cell comes in
contact with a tumor cell there is a probability that the immune cell
will lyse the tumor cell. This rule corresponds to the rule for tumor
cell death due to the immune system using equation (7).
• If the immune cell is a NK cell it is destroyed along with the
tumor cell. Furthermore, the CA element is flagged for the
induction of the specific immune system (through CTLs) at the
next time step.
• If the immune cell is a cytotoxic T lymphocyte, the effectiveness
of the cell is reduced - that is, the number of remaining tumor
cell kills, κ, is reduced by one.
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• If the immune cell is a cytotoxic T lymphocyte, the surrounding
CA elements are sampled for further CTL induction. For each
neighboring free cell a random number is compared with
(11) PL = exp
−
 θL∑
j∈η
Tj

2 ,
to determine whether or not further induction is initiated. In
the expression for PL the summation counts the number of tu-
mor cells, T , in the neighborhood, η, of the relevant CA element,
and θL is a parameter determining the shape of the probability
curve. This lymphocyte recruitment facilitates the satellitosis
where T cells have been observed surrounding tumor cells un-
dergoing apoptosis [69]. For completeness we note that for a
neighboring tumor cell count of zero, PL is defined to be zero
also.
Immune cell death. CTLs are assumed to die by one of two means.
Firstly, they become functionally useless (and therefore, not tracked by
the program) when their cell kill value κ is reduced to zero. Secondly,
the CTLs will die off or move away from the domain of interest if they
no longer detect tumor cells in their neighborhood. This death occurs
with probability
(12) PLD = 1− exp
−
 θLD∑
j∈η
Tj

2 ,
where the summation counts all tumor cells in the neighborhood of
the immune cell, θLD is a parameter determining the shape of the
probability curve, and the probability of immune cell death is defined
to be unity when there are no tumor cells nearby.
Immune cell migration. Immune cells that do not encounter a
tumor cell at some point in time will continue to move randomly about
the domain of interest.
• If there are tumor cells in neighboring CA elements, the immune
cell will choose to attack one of these at random.
• If there are no tumor cells in neighboring CA elements, the
immune cell will choose an element at random and move there.
We point out that while tumor antigenicity is not a direct component
of these CA rules, antigenicity levels can be reflected in the model
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through the adjustment of the immune production and recruitment
parameters, such as Pnk, PL and θL.
Together, these cell rules and the partial differential equations de-
scribe the evolution of the tumor-immune system environment under
consideration. To model an emerging tumor, the initial state of the
system is taken as follows. The cellular automata grid houses a sin-
gle mutated cancer cell along with the normal level, I0, of natural
killer immune cells. The remainder of space available to cells is occu-
pied by non-tumorous host cells. As in other similar models (such as
[2, 26, 27, 49]), the nutrient species are assumed to be in a temporal
steady-state distribution throughout the domain since the timescale
for nutrient diffusion is known to be much shorter than the timescale
for cell metabolism. The steady-state distribution being determined
during the initial calculation of solutions to equations (4)–(5).
4. Simulations and Results
The model described in the previous section was implemented using
MATLAB Release 13 [43]. The dimensionless parameter values α, λM
and λN and shape parameters for tumor cell behavior have been cho-
sen to correspond with those used by Ferreira et al. [26] for similar
growth simulations. The shape parameters for the probabilities related
to immune cell dynamics are unknown and will be investigated in this
section.
The solution of the model proceeds via a sequence of steps and a
summary of this algorithm is given below.
(1) Assign parameter values, discretise spatial domain and con-
struct cell data structures with initial conditions.
(2) Solve steady-state PDEs with dependence upon initial cell con-
ditions, to obtain initial chemical concentrations.
(3) Loop over the required number of time steps or until stop con-
ditions are satisfied:
i. Assign random number to all CA locations for use in de-
ciding actions of cells.
ii. For each cell location in turn, calculate probabilities of the
relevant cell action (that is, tumor cell death, migration,
division, or immune cell death, migration and induction),
depending upon the random number assigned above and
the calculated nutrient concentrations.
iii. Update the cell data structures according to the probabili-
ties and random actions decided upon above.
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iv. Recalculate the nutrient concentrations resulting from the
changed cell conditions.
v. Stop if tumor reaches domain edge or is eradicated, other-
wise proceed to next time step and return to i.
The initial conditions are always taken to be a single, mutated cell,
so we do not consider sensitivity to the initial tumor cell distribution.
For all results shown and discussed in the text to follow, at least 20
simulations have been carried out in order to give a general result
for the parameter sets reported. Unfortunately the simulations are
computationally-intensive and further investigation is therefore quite
difficult.
4.1. Immune system-free growth. Our findings confirm those of
Ferreira et al. [26], [27], in which simulations show that tumor mor-
phology is dictated by relative consumption rates: lower consumption
rates lead to more compact tumors while relatively higher consumption
rates lead to a branchier morphology. Furthermore, we have found that
it is indeed possible to simulate tumors that grow first exponentially,
then linearly and finally reach a steady-zone of existence. Unlike the
deterministic model of Greenspan [34], the stochasticity of this model
means that small fluctuations in the tumor size are still observed -
however, it can be claimed that the tumor is in a zone of stability with
regard to the total number of tumor cells in the mass.
Figure 2(a) shows the growth in the total number of tumor cells
over time when the tumor is allowed to grow in the absence of any
immune response. Note the initially exponential growth phase (iter-
ation 0 through 200), before a phase of linear growth (iteration 200
through 800). These growth characteristics mimic the growth rates
of multicell spheroids described experimentally by Folkman [31] and
mathematically by Greenspan [34].
Figure 2(b) displays the state of the system after 800 iterations. A
roughly circular tumor with a radius of about 200 cells has developed
in the center of the domain and is growing steadily toward the sources
of the nutrient. Higher tumor cell densities are seen at the periphery of
the tumor where it is surrounded by normal cells comprising the host
tissue. In the center of the tumor a necrotic core is beginning to form
with some necrotic material already appearing. The tumor shown is
growing in a domain that is approximately 10−20mm square, and over
a time period of at least a year.
Using similar parameter values to those used by Ferreira et al. [26],
we reproduce the papillary tumor results from the same paper to pro-
vide a base point for a later consideration of the effects of the immune
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(a) Total tumor cell count over time. (b) Tumor cell distribution over the cel-
lular automata grid.
Figure 2. Compact tumor growth in the absence of im-
mune system interaction. Parameter values are: Domain
size of 1000 elements ≈ 10− 20mm, tend = 800 cell divi-
sion cycles, θnec = 0.03, θdiv = 0.3, θmig = 1000, λn = 50,
λm = 25,α = 1, I0 = 0. Note the beginning of a necrotic
core in Figure 2(b).
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(a) Total tumor cell count over time. (b) Final tumor cell distribution over
the cellular automata grid.
Figure 3. An example of papillary tumor growth in the
absence of immune system interaction. Parameter values
are: Domain size of 250 elements≈ 2.5−4mm, tend = 597
cell cycles, θnec = 0.03, θdiv = 0.3, θmig = 1000, λn = 100,
λm = 10,α = 2, I0 = 0.
system. In relation to Figure 2, the coefficients in the nutrient PDEs
have been changed such that the rate of consumption by tumor cells
of the mitosis nutrient is doubled, while the consumption rate of the
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survival nutrient is decreased by more than half. This allows the tu-
mor cells to divide more rapidly in the direction of the nutrient supply
and leads to the “branchy” nature of the resulting tumor shown in
Figure 3(b). Note also that a much larger domain size was used in
Figure 2 as when the domain sizes are smaller (as in Figure 3), the
compact tumor grows quickly to completely cover the domain shown
and is less rounded in shape. We have used different domain sizes in
order to best show the growth pattern of the two tumor types, prior to
vascularization.
Figure 3(a) shows the tumor cell count over time and it can be ob-
served that the tumor is growing exponentially throughout the time
considered without moving to a linear growth rate (as is seen in Fig-
ure 2(a)). It appears that this is due to the shape of the tumor and
the lower requirements of the tumor cells for survival nutrient. Unlike
the spherical tumors for which the cell-dense periphery limits the dif-
fusion of nutrients to the tumor center, the papillary tumor exhibits a
fast expansion from its origin and does not form a cell-dense periphery.
Nutrient diffusion throughout the domain is easier and more cells are
provided with the nutrients to both survive and divide.
4.2. The effects of the immune system. In this section we inves-
tigate the changes to tumor growth when an immune system is intro-
duced to the model. A review of relevant literature suggests that an
appropriate range of values for I0, the normal level of NK cells, is quite
broad. For example Kaufmann (in Lin [41]) suggests that the lympho-
cyte to tumor cell ratio can be anywhere from 5:1 to 1:100, depending
on the tumor cell line. Cerwenker and Lanier state that up to 15% of
lymphocytes are natural killer cells [18], and with lymphocytes com-
prising 1012 of the human body’s 1013−1014 cells [25], this gives a range
for I0 of between 0.1% and 1%.
Throughout the simulations to be presented we will employ a value
of I0 = 0.01 or 1%. Values above this were found to swamp the early
development of tumors, and would therefore be indicative of an immune
system of quite effective strength. For immune levels below 1%, little
effect due to the immune system was evident, and while this would
be indicative of a very weak immune system we do not investigate
these possibilities due to their similarities to the immune system-free
simulations of section 4.1.
Figures 4 show the effect on tumor (left figures) and total immune
(right figures) cell populations, that is the sum of NK and CTL cell
populations, due to changes in the CTL recruitment parameter θL. All
figures were produced with the same parameters as Figures 2 (except for
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Figure 4. The effect on tumor and total (NK+CTL)
immune cell distributions in compact tumors over time
due to changes in CTL recruitment rates (i.e. changes in
θL). Parameter values are: Domain size of 250 elements
≈ 2.5 − 4mm, θnec = 0.03, θdiv = 0.3, θmig = 1000,
λn = 100, λm = 10, α = 2, I0 = 0.01, θLD = 0.3.
the immune parameters) and show oscillatory population cell counts for
both tumor and total immune cells. While these results apply directly
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to the simulations using compact-tumor parameters, qualitatively sim-
ilar results were observed for simulations using the papillary-tumor
parameters.
Figures 4(a)-4(b) show solutions for the lowest value of θL, when
recruitment of CTLs following NK-induced tumor cell apoptosis is high,
and very few oscillations are observed. The tumor grows exponentially
to around 15 cells before immune recognition which decreases the tumor
size. The tumor begins another growth stage at iteration 25, as it has
undergone sufficient shrinkage to evade the immune cells present at
that time. The tumor grows to 35 cells, before the immune system
again detects it and fully eradicates the growth at iteration 42. While
it appears in Figure 4(b) that little has changed in the immune cell
population, the important factor is the location of the immune cells.
After detection of the tumor, the immune cells are attracted to the
location of the tumor mass, thus aiding in its removal.
For θL = 5, solutions are shown in Figures 4(c)-4(d). The tumor
cell population is quite oscillatory and is almost reduced to zero on a
number of occasions. However, over time the tumor cell population
grows to a somewhat steady level, oscillating between 150 and 550
cells. A number of simulations carried out with this parameter set
also exhibited this almost stable, oscillatory behavior. These results
are similar to the purely-temporal results of Kirschner and Panetta
[37] where oscillations were also observed in effector and tumor cell
populations. Experimental evidence for such oscillatory behavior can
also be found in works such as that due to Krikorian et al. [38] regarding
non-Hodgkin’s lymphoma.
In Figures 4(e)-4(f) the tumor and total immune cell populations
are shown for the case where CTL induction is low. In this example,
the tumor cell population is only slightly oscillatory. Furthermore,
the population grows exponentially (although at a slower rate than in
Figures 2) for the majority of the simulation. Near the end of the
observed period of time, the tumor cell population begins to oscillate
around 14000 cells. In other simulations using this parameter set, the
low recruitment of T cells leads to the tumor undergoing unstable,
oscillatory growth where it appears to be growing without any bounds
due to the immune system. While the stochastic nature of the model
leads to difficulties in determining when the solution behaviors change,
simulations indicated that tumor growth becomes unstable for values
of the CTL recruitment parameter near θL = 5.5.
Figures 5 show the effect on tumor (left figures) and total immune
(right figures) cell populations due to changes in the CTL death para-
meter θLD. All figures were produced with the same parameters as the
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(f) θLD = 0.7.
Figure 5. The effect on tumor and total (NK+CTL)
immune cell distributions in compact tumors over time
due to changes in CTL death rates (i.e. changes in θLD).
Parameter values are: Domain size of 250 elements ≈
2.5− 4mm, θnec = 0.03, θdiv = 0.3, θmig = 1000, λn = 50,
λm = 25, α = 2, I0 = 0.01, θL = 3.
compact tumor in Figures 2 (except for the immune parameters) and
again, oscillatory population cell counts are observed for both tumor
and the total population of immune cells. Note that qualitatively simi-
lar results were also observed for simulations using the papillary-tumor
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parameters, although the change from stable-oscillatory to unstable-
oscillatory growth occurred at a slightly higher θLD value for the pap-
illary tumors.
Figures 5(a)-5(b) show solutions for the lowest value of θLD, indicat-
ing lower probabilities of CTL death in regions of low tumor presence.
The solution shows a tumor cell population with basically two oscil-
lations before eradication. Note that after the first response by the
immune system, a 50 cell tumor is reduced to only one cancerous cell.
Exponential growth again occurs before a complete eradication of the
tumor by the immune cells.
The second row of figures (Figures 5(c)-5(d)) show tumor and total
immune cell populations over time for θLD = 0.5. That is, a higher
probability of CTL death when tumor cell levels are low. Again the tu-
mor cell population oscillates, although about six times longer than the
previous example and with tumor populations approximately six times
greater in the largest oscillations. This tumor is however, eventually
destroyed by the response of the immune system.
In the final pair of solution plots, Figures 5(e)-5(f), unstable oscil-
latory tumor growth is evident. Here the CTL death parameter is set
to θLD = 0.7, which is a substantially lower death probability than
for the first pair of Figures 5 where tumor destruction was quite fast.
In this simulation, it appears that initially the tumor is in a phase
of somewhat stable, oscillatory growth. However, near the end of the
simulation (where the tumor reached the edge of the spatial domain),
the tumor cell population appears to have broken out of this stable
pattern and is growing in an unstable manner. Simulations indicated
that tumor growth for compact-tumor simulations becomes unstable
when the CTL death parameter was set near θLD = 0.58, while for
papillary-tumor parameters the critical parameter value was approxi-
mately θLD = 0.63.
4.3. Lymphocyte infiltration. In this section we present a particu-
larly interesting application of the model which produces simulations
that are qualitatively similar to the results of some recent experimen-
tal studies. Recent experimental studies have discussed the relationship
between increased survival rates of cancer patients, tumor necrosis and
fibrosis, and the presence of intratumoral T cells, or infiltrated T lym-
phocytes [66, 69, 77]. The results shown in Figures 6 simulate the
infiltration of immune cells into a growing tumor. These are seen in
the darker regions of Figure 6(b) where tumor cell necrosis has oc-
curred, and in the lighter regions of Figure 6(d) where the immune cell
numbers are highest. These solution plots are similar to experimental
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Figure 6. Immune cell infiltration into a growing tu-
mor. (a) and (b) show the tumor cell count over time
and the final tumor cell distribution over the cellular au-
tomata grid, while the same outputs for total immune
cells are shown in (c) and (d). Parameter values are:
Domain size of 250 elements ≈ 2.5 − 4mm, tend = 354
cell division cycles, θnec = 0.03, θdiv = 0.3, θmig = 1000,
λn = 50, λm = 25,α = 1, I0 = 1%, θL = 9, θLD = 0.9.
Computations were halted when the tumor cells reached
the edge of the computational domain. (e) and (f) show
T cell infiltration in ovarian carcinoma (from [77] used
with permission, copyright c©Massachusetts Medical So-
ciety, 2003) and colon metastasis (from [66] used with
permission, copyright c© National Academy of Sciences,
2003), respectively.
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results shown by Schmollinger et al. [66], Soiffer et al. [69], and Zhang
et al. [77] where strings of immune cells are moving into the tumor,
surrounding individual cells and causing tumor cell necrosis.
The simulation shown uses parameters for a compact tumor (in the
absence of the immune system), low level CTL recruitment and low
CTL death probability. Here we note that the tumor is able to continue
to grow in size even though its structure is depleted in a random manner
and necrotic regions are visible throughout the tumor. Essentially, the
immune system is chasing the tumor but unable to successfully contain
it due to the excessive proliferation of the tumor cells.
A number of experimental studies have produced similar patterns
of tumor infiltration by immune cells as those found through solution
of the mathematical model developed in this paper (see for example,
[66, 69, 77]). Shown in Figure 6(e) are patterns of T cell infiltration
in ovarian carcinoma (taken from [77]). Tumor cells (blue) have been
extensively infiltrated by the immune cells (gray). In Figure 6(f), a
colon metastasis (blue cells) has been extensively infiltrated by CD8+
T cells (black) (taken from [66]). Small areas of tumor necrosis (white)
can be seen in the region of the immune cells.
Figures 7 show the infiltration of T cells into the growing tumor
over time and the resulting tumor destruction. In this simulation, the
greater T cell recruitment and lower death rate (compared with the
parameters for Figures 6) cause an early and strong immune response
to the young tumor, as seen in Figures 7(a)-7(e). Over the remainder
of the period of growth, up until total destruction at iteration 256, the
tumor cell population undergoes oscillatory growth. The tumor cells
grow away from the immune cells in an attempt to evade them, while
the immune cells are constantly directed to surround and kill the tumor
cells. Eventually the cell division of the tumor cells is not sufficient to
exceed the level of cell lysis by immune cells and the tumor is destroyed.
5. Conclusion
We have employed a moderately complex, hybrid cellular automata-
partial differential equation model to describe interactions between a
growing tumor and the immune system.
The model includes both the growth dynamics of tumors and the
effects on tumor growth of the innate and specific immune systems.
Each tumor cell is given the opportunity to move or divide, and is killed
when the local survival nutrient levels are too low. The immune system
is modeled by the inclusion of both natural killer cells and cytolytic T
lymphocytes, both of which are able to lyse cancer cells. While NK cells
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Figure 7. Six time frames of immune cell infiltration
into a growing tumor leading to tumor destruction.
Heavy damage is inflicted early in the tumor growth
process. Parameter values are: Domain size of 250 el-
ements ≈ 2.5 − 4mm, tend = 256 cell division cycles,
θnec = 0.03, θdiv = 0.3, θmig = 1000, λn = 50, λm = 25,
α = 1, I0 = 1%, θL = 4, θLD = 0.4.
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can kill only one tumor cell, this initial detection of mutated cells leads
to recruitment of specific immune cells (CTLs) that are able to lyse
tumor cells many times. The probability of tumor cell lysis by immune
cells is increased for strong local immune systems. A background level
of NK cells is maintained over time to allow for the innate immune
system’s surveillance role. After lysing a tumor cell, T lymphocytes
continue to roam the domain in search of further target cells, although
they may move out of the domain of interest or die if the local tumor
cell density is low.
In the absence of the immune system, the model is able to reproduce
tumors of both compact-circular and papillary morphologies. These
tumor shapes have direct dependence on the relative rates of consump-
tion of the survival and mitosis nutrients by both tumor and host tissue
cells. For circular tumors, the two-dimensional analogue of the spher-
ical tumor, simulations show the presence of necrotic cores and outer
bands of proliferating cells. These results correspond qualitatively with
the experimental literature (such as Folkman [31]).
Introducing the immune system to the model leads to various re-
sults depending on the choice of T lymphocyte recruitment and death
parameters. For virtually all immune system parameter choices, the re-
sulting solutions displayed oscillatory behavior for tumor and immune
cell populations in a similar manner to ODE models of tumor-immune
system interactions. Depending on the strength of T cell recruitment
and the T cell death parameter, the tumor grew with stable or unsta-
ble oscillations and in some cases the tumor was destroyed completely.
Due to the probabilistic nature of the model, it is difficult to determine
exact parameter values at which the tumor growth becomes unstable.
For the parameter sets shown in Figures 4 and 5, approximate values
determined through repeated simulation are given in Section 4.2.
The varying parameter value sets correspond to strong immune sys-
tems of healthy individuals, capable of early tumor detection and de-
struction, and weaker immune systems of individuals for whom tumors
grow easily or are at least able to grow to the point of metastasis and
hence migrate throughout the body. Furthermore, simulations indi-
cate that (as would be expected) increasing lymphocyte recruitment
and increasing the cytolytic ability of lymphocytes leads to greater re-
ductions in tumor size. Such lymphocyte recruitment could be effected
through vaccinations with irradiated tumor cells, engineered to secrete
chemo-attractants such as those used in the work of Schmollinger et al.
[66].
Finally, we used the model to demonstrate T cell infiltration into tu-
mor growths. Experimental literature has shown that greater survival
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rates are observed in patients with lymphocyte infiltrates in tumors.
Using the model proposed in this paper we have determined the para-
meter regimes in which infiltration is effective in tumor destruction. It
is the subject of another study of the authors’ to model the effects of
injected T cells and T cell infiltration on pre-grown tumors.
There is clinical evidence that immune cells play an important role
in the control of certain malignancies, a fact that is exploited in the
development of immunotherapies for cancers (see, for example [9, 19,
20, 48, 65, 75]). Of the large array of immunotherapy types available,
one that might be readily included in this model structure is the direct
injection of tumor infiltrating lymphocytes (see, for example, [24]). In
future studies, the model employed here will be extended to consider
the effects of immunotherapy on the interactions between the immune
system and growing tumors.
In summary, while the cellular automata rules proposed in this model
are not definitive choices, we have successfully proposed a framework
for including the immune system in a hybrid CA-PDE model of tu-
mor growth. The resulting solutions are in qualitative agreement with
both the experimental and theoretical literature, including both PDE
models of tumor growth and ODE models of tumor-immune system in-
teractions. It has been shown that the simple description proposed here
regarding immune and tumor cell interactions, and the use of hybrid
CA-PDE models, have the potential to produce the behavior observed
in some experiments. What needs to follow this work is an exploration
of the robustness of the model to different functional forms, as well
as the derivation of actual parameters and accurate functional forms
from experimentalists. With the introduction of such elements it will
be possible to judge if this is actually how the observed phenomena
occur and if this modelling strategy is appropriate.
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